Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.

Post-acquisition, the DMGT-backed online vehicle marketplace's valuation will be nearly three times that of its last funding round five months ago.

The Tencent-backed vertical take-off and landing jet developer is joining forces with the Nasdaq-listed Qell Acquisition Corp.

The Agilent Technologies-backed tissue analysis device maker has selected the Nasdaq Global Select Market for its initial public offering.

Novo, Sanofi and Merck & Co all scored exits as the cancer drug developer, which had been spun off by Biox Biosciences, floated in a $101m offering.

The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.

SoftBank-backed co-working space provider WeWork will finally get a public listing, at a $9bn initial enterprise value.

The Alphabet and Tencent-backed automation software producer, valued at $35bn as of last month, has filed for a $1bn offering.

The Novo-backed musculoskeletal disease therapy developer floated in an upsized IPO before its share price almost doubled on its first day of trading.

Bristol Myers Squibb has scored an exit from oncology therapy deveoper Ikena, whose share priced doubled on its first day of trading.